Jump to content

Definition:No-leakage warranty

From Insurer Brain

🔒 No-leakage warranty is a contractual commitment given by the seller in an insurance M&A transaction — typically structured on a locked-box basis — guaranteeing that no value has been extracted from the target company between the locked-box date and completion. In insurance deals, where cash flows from premiums, claims payments, reinsurance settlements, and commissions move continuously through the business, the warranty serves as the buyer's primary protection against the seller siphoning economic value after the reference balance sheet date has been set.

⚙️ Under a locked-box structure, the purchase price is fixed by reference to a historical balance sheet — the "locked-box date" — rather than adjusted through completion accounts prepared after closing. The no-leakage warranty plugs the gap between that date and the day the deal actually closes by requiring the seller to warrant that it has not caused or permitted any "leakage": dividends, management fees, intercompany loan repayments, bonus payments, asset transfers, or any other flow of value from the target to the seller or its affiliates. In insurance-specific transactions, the definition of prohibited leakage is often tailored to capture items like upstream quota share commissions to a parent, extraction of investment income from the insurance float, acceleration of profit commissions, or transfers out of fiduciary accounts. Permitted leakage — ordinary-course items that both sides agree are acceptable, such as routine salary payments and normal claims settlement — is carved out in a schedule attached to the SPA.

💡 The warranty matters because it gives the buyer certainty that the enterprise value it priced on the locked-box date has not been eroded before it takes control. If leakage is discovered after closing, the seller is liable to refund the amount on a dollar-for-dollar basis, making it a powerful deterrent. For insurance targets, where regulatory capital adequacy is closely monitored by supervisors — whether under Solvency II in Europe, the RBC framework in the United States, or C-ROSS in China — unauthorized extraction of value could also jeopardize the target's solvency position, creating regulatory as well as commercial consequences. As a result, no-leakage warranties in insurance transactions tend to be more granular and heavily negotiated than in other sectors.

Related concepts: